conivaptan has been researched along with Hyponatremia in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.08) | 18.2507 |
2000's | 49 (52.69) | 29.6817 |
2010's | 43 (46.24) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greenberg, A; Lehrich, RW; Ortiz-Melo, DI; Patel, MB | 1 |
Aghi, MK; Blevins, L; Jahangiri, A; Kunwar, S; Miller, LM; Tom, MW; Tran, MT; Wagner, J | 1 |
Blevins, LS; Breshears, JD; Jiang, B; Kunwar, S; Rowland, NC | 1 |
Buckley, MS; Culver, MA; Hattrup, AE; Jacobs, SC; Kazem, NH; Patel, SA | 1 |
Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K | 1 |
Iwao, H; Izumi, Y; Miura, K | 1 |
Adams, KF; Lin, TE; Patterson, JH | 1 |
Tanındı, A; Töre, HF | 1 |
Palmer, BF; Rock, AD; Woodward, EJ | 1 |
Bhandari, S; Cranston, I; Glanville, J; McCool, R; O'Reilly, K; Peri, A; Petrakova, L; Shaw, A | 1 |
Berger, K; Der-Nigoghossian, C; Lesch, C | 1 |
Laczi, F | 1 |
Chini, B; Durroux, T; Guillon, G; Manning, M; Mouillac, B; Stoev, S | 1 |
Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT | 1 |
Kumar, SK; Mather, PJ | 1 |
Keating, GM; Moen, MD | 1 |
Asbury, WH; Gilmore, JL; Samuels, OB; Wright, WL | 1 |
Annane, D; Decaux, G; Smith, N | 1 |
Dhar, R; Diringer, M; Murphy, T | 1 |
Arai, Y; Fujimori, A; Miyata, K; Sasamata, M | 1 |
Elhassan, E; Masoumi, A; Schrier, RW | 1 |
Krahn, TA; Mount, DB | 1 |
Afiniwala, M; Arumugham, P; Hoque, MZ; Huda, N; Karia, DH; Verma, N | 1 |
Keirns, J; Mao, ZL; Stalker, D | 1 |
Davis, GL; O'Leary, JG | 1 |
Haass, M | 1 |
Arthur, JM; Delay, TA; Dopson, SJ; Sanders, DS; Velez, JC | 1 |
Gross, P | 1 |
Keegan, MT; Wright, DR | 1 |
Reilly, T; Schork, MR | 1 |
Bar-Or, D; Garrett, RE; Maerz, G; Wilhelm, S | 1 |
Dhar, R; Murphy-Human, T | 1 |
Ghali, JK; Tam, SW | 1 |
Carluccio, AL; Merlin, MA; Zenenberg, RD | 1 |
Hopkins, JP; Oliphant, CS; Pinner, NA | 1 |
Alberts, MJ; Bassin, SL; Bernstein, RA; Leibling, SM; Levasseur, K; Liebling, SM; Muro, K; Naidech, AM; Paparello, J | 1 |
Blevins, LS; McDermott, M; Sughrue, ME | 1 |
Komai, Y; Palaniyandi, SS; Sukumaran, V; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
Singh, M; Slawsky, MT; Valania, G | 1 |
Chiong, JR; Jao, GT | 1 |
Cantillo, DS; Comín Colet, J; Robledo, GG | 1 |
Villabona, C | 1 |
Hix, J; Sterns, R | 1 |
Abeyratne, A; Arthur, JM; Efrati, S; Kalra, S; Klasen, S; McNutt, BE; Oliven, A; Velez, JC | 1 |
Decaux, G; Gross, PA; Wagner, A | 1 |
Abeyratne, A; Hamad, A; Kalra, S; Klasen, S; Koren, MJ; McNutt, BE | 1 |
Bianzina, S; Dal Canton, A; Esposito, P; Malul, Y; Piotti, G | 1 |
Blevins, LS; DeGiacomo, AF; Deragopian, L; Potts, MB | 1 |
Cassagnol, M; Saad, M; Shogbon, AO | 1 |
Fujiwara, Y; Koshimizu, TA; Tanoue, A; Tsujimoto, G | 1 |
Caimi, G; Urso, C | 1 |
Alemayehu, A; O'Connell, JB | 1 |
Dhar, R; Diringer, M; Human, T; Onuoha, A | 1 |
Dabrowska, MD; Krysiak, R; Okopień, B | 1 |
Cirulli, J; Friedman, B | 1 |
Balaguru, D; Bricker, JT; Haque, I; Pham-Peyton, C; Sahu, R; Thapar, V | 1 |
Marik, PE; Rivera, R | 1 |
Peri, A | 1 |
Doggrell, SA | 1 |
Brooks-Asplund, E; Fan, K; Ghali, JK; Koren, MJ; Long, WA; Smith, N; Taylor, JR | 1 |
Pham, PC; Pham, PM; Pham, PT | 1 |
Greenberg, A; Verbalis, JG | 1 |
Gross, P; Quittnat, F | 1 |
O'Connor, CM; Starling, RC; Wagoner, LE | 1 |
Gross, P; Herbrig, K; Palm, C; Pistrosch, F | 1 |
Verbalis, JG | 1 |
Ginès, P; Guevara, M; Martín-Llahí, M | 1 |
Hays, RM | 1 |
Arai, Y; Fujimori, A; Matsukawa, U; Miyata, K; Sasamata, M; Sudoh, K; Wada, K | 1 |
Oh, MS | 1 |
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P | 1 |
Balk, RA; Patel, GP | 1 |
Berl, T; Ellison, DH | 1 |
Walter, KA | 1 |
Rosansky, S; Smith, N; van Rensburg, H; Verbalis, JG; Zeltser, D | 1 |
Lien, YH; Shapiro, JI | 1 |
Kumar, S; Mather, PJ; Rubin, S; Whellan, DJ | 1 |
Ali, F; Ghali, JK; Raufi, MA; Washington, B | 1 |
Haskal, R | 1 |
Głuszek, J; Olszewski, W | 1 |
Andoh, M; Barve, A; Smith, N; Verbalis, JG; Zeltser, D | 1 |
Cárdenas, A; Ginès, P | 1 |
Siegel, AJ | 1 |
DeVita, MV; Metzger, BL; Michelis, MF | 1 |
Schweiger, TA; Zdanowicz, MM | 1 |
Cain, JP; Rianthavorn, P; Turman, MA | 1 |
Decaux, G; Soupart, A; Vassart, G | 1 |
Honda, K; Iizumi, Y; Kusayama, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Wada, K; Yatsu, T | 1 |
Bichet, DG; Davids, MR; Edoute, Y; Halperin, ML; Mallie, JP | 1 |
Martinez-Castelao, A | 1 |
55 review(s) available for conivaptan and Hyponatremia
Article | Year |
---|---|
Role of vaptans in the management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Humans; Hyponatremia; Male; Middle Aged; Pyrroles; Tolvaptan | 2013 |
Conivaptan for treatment of hyponatremia in neurologic and neurosurgical adults.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Neurosurgical Procedures | 2013 |
Management of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome | 2014 |
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Prospective Studies; Tolvaptan; Vasopressins | 2014 |
[Use of "Vaptans" in treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Contraindications; Humans; Hyponatremia; Tolvaptan | 2015 |
A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Osmotic Pressure; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2017 |
[Etiology, diagnostics and therapy of hyponatremias].
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins | 2008 |
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Lypressin; Oligopeptides; Oxytocin; Peptides; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Structure-Activity Relationship; Terlipressin; Uterus; Vasodilator Agents; Vasopressins | 2008 |
Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Assessment; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance | 2008 |
AVP receptor antagonists in patients with CHF.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Sodium | 2009 |
New topics in vasopressin receptors and approach to novel drugs: research and development of conivaptan hydrochloride (YM087), a drug for the treatment of hyponatremia.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Humans; Hyponatremia; Research Design | 2009 |
Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Humans; Hyponatremia; Kidney; Kidney Diseases; Vasopressins | 2009 |
[Vasopressin receptor antagonists and heart failure].
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Female; Follow-Up Studies; Furosemide; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Indoles; Male; Morpholines; Platelet Aggregation Inhibitors; Pyrroles; Pyrrolidines; Sodium Potassium Chloride Symporter Inhibitors; Spiro Compounds; Time Factors; Tolvaptan | 2009 |
Tolvaptan (Samsca) for hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Approval; Drug Interactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Tolvaptan; United States; United States Food and Drug Administration | 2009 |
Sodium, potassium and glucose management in organ transplantation.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Glucose; Fluid Therapy; Humans; Hyperglycemia; Hyperkalemia; Hypoglycemia; Hypoglycemic Agents; Hyponatremia; Organ Transplantation; Perioperative Care; Potassium; Sodium; Transplantation, Homologous; Treatment Outcome | 2010 |
Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.
Topics: Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Neurotransmitter Agents; Pyrroles; Tolvaptan; Vasopressins | 2010 |
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Blood Pressure; Blood Volume; Female; Heart Failure; Humans; Hypertension; Hyponatremia; Male; Prevalence; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; United States; Water-Electrolyte Balance | 2010 |
Hyponatremia: evaluation and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; Cardiac Output, Low; Causality; Diagnosis, Differential; Glomerular Filtration Rate; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules; Saline Solution, Hypertonic; Sodium; Tolvaptan; Uric Acid; Water-Electrolyte Balance | 2010 |
Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Drug Evaluation, Preclinical; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan | 2010 |
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins | 2011 |
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Fluid Therapy; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Receptors, Vasopressin; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Ventricular Dysfunction | 2010 |
[Hyponatremia in heart failure: physiopathology and pharmacological approach].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Brain Edema; Demyelinating Diseases; Diuresis; Diuretics; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Kidney; Multicenter Studies as Topic; Natriuresis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Renin-Angiotensin System; Saline Solution, Hypertonic; Sympathetic Nervous System; Tolvaptan | 2010 |
[Vasopressin receptor antagonists: the vaptans].
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins | 2010 |
Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Costs; Humans; Hyponatremia; Inappropriate ADH Syndrome; Tolvaptan | 2011 |
The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options.
Topics: Animals; Benzazepines; Disease Management; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neurophysins; Protein Precursors; Vasopressins; Water-Electrolyte Balance | 2011 |
The therapeutic use of vaptans for the treatment of dilutional hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Interactions; Humans; Hyponatremia; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance | 2011 |
The roles of V1a vasopressin receptors in blood pressure homeostasis: a review of studies on V1a receptor knockout mice.
Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Blood Volume; Heart Failure; Homeostasis; Humans; Hyponatremia; Mice; Receptors, Vasopressin; Renin-Angiotensin System | 2012 |
[Hyponatremic syndrome].
Topics: Aging; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Brain Edema; Exercise; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infections; Inflammation; Kidney; Natriuresis; Neoplasms; Osmotic Pressure; Renal Replacement Therapy; Sodium; Tolvaptan; Water Intoxication | 2012 |
Hyponatremia, heart failure, and the role of tolvaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Heart Failure; Humans; Hyponatremia; Prognosis; Tolvaptan; Treatment Outcome | 2012 |
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan | 2012 |
Hyponatremia in critical care patients: frequency, outcome, characteristics, and treatment with the vasopressin V2-receptor antagonist tolvaptan.
Topics: Age Factors; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Temperature; Creatinine; Critical Care; Health Status Indicators; Humans; Hyponatremia; Intensive Care Units; Prevalence; Tolvaptan; Water-Electrolyte Imbalance | 2013 |
Clinical review: the use of vaptans in clinical endocrinology.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Discovery; Endocrinology; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Models, Biological; Tolvaptan | 2013 |
Vasopressin excess and hyponatremia.
Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance | 2006 |
Vasopressin receptor antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins | 2006 |
Vaptans and the treatment of water-retaining disorders.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan; Vasopressins; Water | 2006 |
Cardiac function and heart failure.
Topics: Adrenergic beta-Antagonists; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Carbazoles; Cardiac Output, Low; Carvedilol; Child; Diuretics; Genomics; Heart; Hemofiltration; Humans; Hyponatremia; Propanolamines | 2006 |
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins | 2006 |
AVP receptor antagonists as aquaretics: review and assessment of clinical data.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance | 2006 |
Hyponatremia in cirrhosis: clinical features and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Brain; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Creatinine; Forecasting; Hepatic Encephalopathy; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Prognosis; Research; Risk Factors; Sodium; Time Factors; Treatment Outcome | 2006 |
Management of hyponatremia and clinical use of vasopressin antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia | 2007 |
Therapeutic potential of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2007 |
Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Critical Illness; Humans; Hyponatremia; Inpatients; Practice Guidelines as Topic; Pyrroles; Randomized Controlled Trials as Topic; Tolvaptan | 2007 |
Clinical practice. The syndrome of inappropriate antidiuresis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Carcinoma, Small Cell; Dysgeusia; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Osmolar Concentration; Saline Solution, Hypertonic; Urine | 2007 |
Conivaptan: new treatment for hyponatremia.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Drug Costs; Drug Interactions; Heart Failure; Humans; Hyponatremia | 2007 |
Hyponatremia: clinical diagnosis and management.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Kidney Concentrating Ability; Kidney Tubules, Collecting; Male; Osmolar Concentration; Vasopressins | 2007 |
Hyponatremia and vasopressin antagonism in congestive heart failure.
Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Models, Biological; Pyrroles; Registries; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Vasopressins | 2007 |
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Molecular Structure; Platelet Aggregation; Treatment Outcome | 2007 |
Current issues for nurse practitioners: Hyponatremia.
Topics: Aged; Algorithms; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Causality; Decision Trees; Diagnosis, Differential; Early Diagnosis; Female; Homeostasis; Humans; Hyponatremia; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Selection; Primary Health Care; Pyrroles; Tolvaptan; Water-Electrolyte Balance | 2007 |
[Vasopressin antagonists in treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance | 2007 |
The management of ascites and hyponatremia in cirrhosis.
Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Diet, Sodium-Restricted; Diuretics; Humans; Hyponatremia; Liver Cirrhosis; Prognosis | 2008 |
Hyponatremia in psychiatric patients: update on evaluation and management.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drinking Behavior; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mental Disorders; Psychotropic Drugs; Risk Factors; Water-Electrolyte Balance | 2008 |
Vasopressin-receptor antagonists in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan | 2008 |
Non-peptide arginine-vasopressin antagonists: the vaptans.
Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Contraindications; Humans; Hyponatremia; Models, Molecular; Receptors, Vasopressin | 2008 |
Conivaptan (Yamanouchi).
Topics: Animals; Benzazepines; Clinical Trials as Topic; Edema; Heart Failure; Humans; Hyponatremia; Technology, Pharmaceutical | 2002 |
8 trial(s) available for conivaptan and Hyponatremia
Article | Year |
---|---|
Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia--efficacy, safety, and pharmacokinetics.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Blood Volume; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Male; Middle Aged; Treatment Outcome; Young Adult | 2016 |
Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia.
Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Humans; Hyponatremia; Male; Middle Aged; Sodium | 2009 |
Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glasgow Coma Scale; Humans; Hyponatremia; Injections, Intravenous; Intensive Care Units; Male; Middle Aged; Pilot Projects; Prospective Studies; Severity of Illness Index; Single-Blind Method; Sodium; Time Factors; Young Adult | 2010 |
Effect of loading dose and formulation on safety and efficacy of conivaptan in treatment of euvolemic and hypervolemic hyponatremia.
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Blood Volume; Chemistry, Pharmaceutical; Female; Follow-Up Studies; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult | 2011 |
Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Water; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyponatremia; Infusions, Intravenous; Least-Squares Analysis; Male; Middle Aged; Sodium; Time Factors; Young Adult | 2011 |
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Female; Humans; Hyponatremia; Male; Sodium | 2006 |
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyponatremia; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Single-Blind Method; Sodium; Time Factors; Treatment Outcome | 2007 |
Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study.
Topics: Aged; Aged, 80 and over; Benzazepines; Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hormone Antagonists; Humans; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Placebos; Sodium; Treatment Outcome | 2008 |
30 other study(ies) available for conivaptan and Hyponatremia
Article | Year |
---|---|
Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Child, Preschool; Female; Humans; Hyponatremia; Hypopituitarism; Inappropriate ADH Syndrome; Male; Middle Aged; Neurosurgical Procedures; Pituitary Gland; Postoperative Complications; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome; Young Adult | 2013 |
Use of conivaptan for management of hyponatremia following surgery for Cushing's disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cushing Syndrome; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Sodium; Water Deprivation | 2013 |
Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cohort Studies; Critical Illness; Female; Humans; Hypokalemia; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2017 |
Intravenous conivaptan.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Hyponatremia; Infusions, Intravenous | 2008 |
Conivaptan for hyponatremia in the neurocritical care unit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Critical Care; Drug Monitoring; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Receptors, Vasopressin; Retrospective Studies; Sodium; Young Adult | 2009 |
Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Critical Care; Dose-Response Relationship, Drug; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pulse Therapy, Drug; Retrospective Studies; Sodium; Specific Gravity; Urine | 2009 |
Hyponatremia: case vignettes.
Topics: Adult; Aged; Benzazepines; Deamino Arginine Vasopressin; Female; Humans; Hyponatremia; Male; Middle Aged; Saline Solution, Hypertonic; Tolvaptan; Treatment Outcome | 2009 |
Conivaptan: promise of treatment in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin | 2009 |
Pharmacokinetics of conivaptan hydrochloride, a vasopressin V(1A)/V(2)-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Half-Life; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Young Adult | 2009 |
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease.
Topics: Adult; Aged; Benzazepines; Drug Administration Schedule; Female; Humans; Hyponatremia; Liver Failure; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk; Sodium; Time Factors; Treatment Outcome | 2009 |
Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Urea Nitrogen; Female; Glomerular Filtration Rate; Hospitalization; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infusions, Intravenous; Male; Middle Aged; Sodium | 2010 |
The vaptans: just landed. But how was the trip?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome | 2010 |
Vasopressin receptor antagonist use in a neurologic rehabilitation center.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Male; Middle Aged; Quadriplegia; Substance Abuse Treatment Centers | 2010 |
A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Injuries; Cerebral Angiography; Female; Humans; Hyponatremia; Intracranial Hypertension; Tomography, X-Ray Computed; Young Adult | 2011 |
Use of conivaptan for the treatment of symptomatic hyponatremia in a patient with acute decompensated heart failure.
Topics: Aged; Benzazepines; Blood Urea Nitrogen; Cardiac Catheterization; Creatinine; Defibrillators, Implantable; Female; Heart Failure; Humans; Hyponatremia; Injections, Intravenous; Receptors, Vasopressin | 2010 |
Extreme correction of hyponatremia in a patient treated with intravenous conivaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Neoplasms; Female; Fourth Ventricle; Humans; Hyponatremia; Injections, Intravenous; Intracranial Aneurysm; Magnetic Resonance Imaging; Sodium; Tomography Scanners, X-Ray Computed; Young Adult | 2010 |
Hyponatremia: vasopressin antagonists in hyponatremia: more data needed.
Topics: Benzazepines; Clinical Trials as Topic; Drug Resistance; Humans; Hyponatremia; Tolvaptan; Vasopressins | 2011 |
Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.
Topics: Adult; Aged; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Middle Aged; Retrospective Studies | 2011 |
Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury.
Topics: Administration, Intravenous; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Brain Injuries; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Sodium | 2012 |
Conivaptan therapy in an infant with severe hyponatremia and congestive heart failure.
Topics: Benzazepines; Female; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Infant; Neurophysins; Protein Precursors; Severity of Illness Index; Treatment Outcome; Vasopressins | 2012 |
Therapeutic effect of conivaptan bolus dosing in hyponatremic neurosurgical patients.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Female; Humans; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Neurosurgical Procedures; Retrospective Studies; Treatment Outcome | 2013 |
Conivaptan Yamanouchi.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Diuretics; Edema; Heart Failure; Humans; Hyponatremia; Molecular Structure; Structure-Activity Relationship; Vasopressins | 2005 |
Conivaptan (Vaprisol) for hyponatremia.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Administration Schedule; Drug Costs; Drug Interactions; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Kidney Tubules, Collecting; Randomized Controlled Trials as Topic | 2006 |
Vasopressin antagonists--progress and promise.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Tolvaptan | 2006 |
A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Osmolar Concentration; Potassium; Rats; Rats, Wistar; Sodium; Water; Water-Electrolyte Balance | 2007 |
Molecule of the Month: Conivaptan hydrochloride.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Humans; Hyponatremia | 2006 |
Observations regarding the use of the aquaretic agent conivaptan for treatment of hyponatremia.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome | 2008 |
Use of conivaptan to allow aggressive hydration to prevent tumor lysis syndrome in a pediatric patient with large-cell lymphoma and SIADH.
Topics: Adolescent; Benzazepines; Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lymphoma, Large B-Cell, Diffuse; Male; Severity of Illness Index; Tumor Lysis Syndrome | 2008 |
[Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Calcium; Cyclic AMP; Dogs; Female; Heart Failure; Humans; Hyponatremia; In Vitro Techniques; Male; Radioligand Assay; Rats; Vasopressins | 1999 |
Body compartment volumes and composition after giving a vasopressin antagonist: changes are revealed by a tonicity balance.
Topics: Benzazepines; Body Fluid Compartments; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Potassium; Receptors, Vasopressin; Sodium | 2002 |